Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Clin Pediatr. Jun 9, 2023; 12(3): 107-114
Published online Jun 9, 2023. doi: 10.5409/wjcp.v12.i3.107
Table 1 DDX58 variants in children with immune-mediated diseases
No.
DDX58 variant
MAF
ClinVar
ACMG
IFN-I score (n.v.0-1.9 UE/L)
Diagnosis
1c1061A>G (p.N354S)0.0001VUSVUS2.13uSAID
2c109G>A (p.E37K)0.000008Not reportedLikely non-pathogenicN/AuSAID
3c.2587_2590dup (p.Cys864fs)0.0006Not reportedLikely pathogenic21.0SLE
c.1740T>A (p.D580E)0.11Non-pathogenicNon-pathogenic
4c.431C>T (p.S144F)0.0277Non-pathogenicLikely non-pathogenic13.31MCTD
5c.T1740A (p.D580E)0.11Non-pathogenicNon-pathogenic8.5SLE and MDS
6c.1740T>A (p.D580E)0.11Non-pathogenicNon-pathogenic24.35SLE
7c.1740T>A (p.D580E)0.11Non-pathogenicNon-pathogenic18.93uSAID
Table 2 IFIH1 variants in children with immune-mediated diseases
No.
IFIH1 variant
MAF
ClinVar
ACMG
IFN-score (n.v. 0-1.9 UE/L)
Diagnosis
1c.2035_2036del (p.L679Ifs*2)0.0001VUSVUS5.4uSAID
c.1795delG (p.V599Ffs*5)Not reportedNot reported
2c.1558A>G (p.T520A)0.0002CIPVUS5.52uSAID
3c.1784G>A (p.R595H)0.0001Likely benignVUS29.0JDM
4c.1879G>T (p.E627X)0.003CIPVUS20.2SLE-like disease
5c.1879G>T (p.E627X)0.003CIPVUS11.3SLE
6c.1879G>T (p.E627X)0.003CIPVUS2.95PFAPA
7c.A2767G (p.I923V)0.0126Benign/likely benignBenign10.0soJIA